Company Overview
Snapshot
Founded in April 2019, Venacore operates with 1–10 employees. The company has secured funding across one round from Med Venture Holdings to advance its medical device development.
Business overview
Venacore is a medical device company focused on the Health Tech & Life Sciences sector. The company is developing a structural intervention occluder designed for the closure of congenital heart defects, specifically engineered to anchor and occlude effectively in large vessels where other plugs may fail. Venacore's technology targets the cardiology market, providing solutions for medical treatment and therapeutics within the healthcare industry.
Log in to access full profile ›Company Intelligence Q&A
- What is Venacore's primary focus?
- Venacore is developing a medical device for structural intervention, specifically an occluder for the closure of congenital heart defects.
- When was Venacore founded?
- Venacore was founded in April 2019.
- What stage is Venacore currently in?
- Venacore is currently in the R&D product stage and Seed funding stage.
- What problem does Venacore's device aim to solve?
- Venacore's device is designed to anchor and occlude effectively in large vessels, addressing limitations where other plugs for congenital heart defects may fail.